113 related articles for article (PubMed ID: 2457160)
1. Drug discrimination in human post-addicts: agonist/antagonist opioids.
Preston K; Bigelow G; Bickel W; Liebson I
NIDA Res Monogr; 1988; 81():209-15. PubMed ID: 2457160
[No Abstract] [Full Text] [Related]
2. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
Preston KL; Bigelow GE
J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
[TBL] [Abstract][Full Text] [Related]
3. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
Preston KL; Bigelow GE
J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination.
Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1992 Apr; 261(1):62-71. PubMed ID: 1373189
[TBL] [Abstract][Full Text] [Related]
5. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Jones HE; Bigelow GE; Preston KL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
[TBL] [Abstract][Full Text] [Related]
6. Drug discrimination in human postaddicts: agonist-antagonist opioids.
Preston KL; Bigelow GE; Bickel WK; Liebson IA
J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
Bickel WK; Stitzer ML; Bigelow GE; Liebson IA; Jasinski DR; Johnson RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):47-53. PubMed ID: 2459370
[TBL] [Abstract][Full Text] [Related]
8. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
Picker MJ
J Pharmacol Exp Ther; 1994 Mar; 268(3):1190-8. PubMed ID: 8138931
[TBL] [Abstract][Full Text] [Related]
9. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
Hameroff SR
Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
[No Abstract] [Full Text] [Related]
10. Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.
Strain EC; Walsh SL; Bigelow GE
Psychopharmacology (Berl); 2002 Jan; 159(2):161-6. PubMed ID: 11862344
[TBL] [Abstract][Full Text] [Related]
11. Assessment of buprenorphine in a drug discrimination procedure in humans.
Bigelow GE; Preston KL
NIDA Res Monogr; 1992; 121():28-37. PubMed ID: 1406908
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
13. Properties of pentazocine as a discriminative stimulus in the squirrel monkey.
White JM; Holtzman SG
J Pharmacol Exp Ther; 1982 Nov; 223(2):396-401. PubMed ID: 7131294
[TBL] [Abstract][Full Text] [Related]
14. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
[TBL] [Abstract][Full Text] [Related]
15. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
France CP; Woods JH
J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
[TBL] [Abstract][Full Text] [Related]
16. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
Schlaepfer TE; Strain EC; Greenberg BD; Preston KL; Lancaster E; Bigelow GE; Barta PE; Pearlson GD
Am J Psychiatry; 1998 Apr; 155(4):470-3. PubMed ID: 9545990
[TBL] [Abstract][Full Text] [Related]
17. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
Moerschbaecher JM; Devia C; Brocklehurst C
J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
[TBL] [Abstract][Full Text] [Related]
18. Using agonist-antagonist opioids and antagonist drugs.
Pasero C; McCaffery M
Am J Nurs; 1999 Jan; 99(1 Pt 1):20, 23. PubMed ID: 9932048
[No Abstract] [Full Text] [Related]
19. On the ability of narcotic antagonists to produce the narcotic cue.
Colpaert FC; Niemegeers CJ; Janssen PA
J Pharmacol Exp Ther; 1976 Apr; 197(1):180-7. PubMed ID: 4610
[TBL] [Abstract][Full Text] [Related]
20. Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.
Young AM; Stephens KR; Hein DW; Woods JH
J Pharmacol Exp Ther; 1984 Apr; 229(1):118-26. PubMed ID: 6142942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
